(-)-demecolcine decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Demecolcine results in decreased expression of SLC25A37 mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC25A37 mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A37 mRNA CTD PMID:22206623 1,2-dimethylhydrazine affects expression ISO Slc25a37 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of SLC25A37 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Slc25a37 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of SLC25A37 mRNA CTD PMID:17555576 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC25A37 mRNA CTD PMID:26496021 17beta-estradiol multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of SLC25A37 mRNA CTD PMID:30165855 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO SLC25A37 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of SLC25A37 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc25a37 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC25A37 mRNA CTD PMID:19770486 and PMID:29673856 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc25a37 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC25A37 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc25a37 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC25A37 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC25A37 mRNA CTD PMID:21215274 2-butoxyethanol increases expression ISO Slc25a37 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of SLC25A37 mRNA CTD PMID:19812364 2-palmitoylglycerol increases expression ISO SLC25A37 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of SLC25A37 mRNA CTD PMID:37199045 3,3',5,5'-tetrabromobisphenol A increases expression ISO Slc25a37 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of SLC25A37 mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine increases expression ISO Slc25a37 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SLC25A37 mRNA CTD PMID:20188158 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC25A37 mRNA CTD PMID:24780913 acrolein multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC25A37 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SLC25A37 mRNA CTD PMID:32699268 aflatoxin B1 increases methylation ISO SLC25A37 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SLC25A37 gene and Aflatoxin B1 results in increased methylation of SLC25A37 intron CTD PMID:28458013 and PMID:30157460 Aflatoxin B2 alpha increases methylation ISO SLC25A37 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of SLC25A37 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO SLC25A37 (Homo sapiens) 6480464 Tretinoin results in increased expression of SLC25A37 mRNA CTD PMID:17218384 alpha-pinene multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC25A37 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SLC25A37 mRNA CTD PMID:32699268 anthracen-2-amine increases expression EXP 6480464 2-anthramine results in increased expression of SLC25A37 mRNA CTD PMID:23038007 aristolochic acid A decreases expression ISO SLC25A37 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SLC25A37 mRNA CTD PMID:33212167 arsenous acid multiple interactions ISO Slc25a37 (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of SLC25A37 mRNA] CTD PMID:29095437 arsenous acid decreases expression ISO Slc25a37 (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of SLC25A37 mRNA CTD PMID:29095437 atrazine increases expression ISO SLC25A37 (Homo sapiens) 6480464 Atrazine results in increased expression of SLC25A37 mRNA CTD PMID:22378314 avobenzone increases expression ISO SLC25A37 (Homo sapiens) 6480464 avobenzone results in increased expression of SLC25A37 mRNA CTD PMID:31016361 benzo[a]pyrene decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC25A37 mRNA CTD PMID:26238291 and PMID:30453624 benzo[a]pyrene multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Ethanol co-treated with Benzo(a)pyrene] results in increased expression of SLC25A37 mRNA CTD PMID:35412187 benzo[a]pyrene affects methylation ISO SLC25A37 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC25A37 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO SLC25A37 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 benzo[e]pyrene increases methylation ISO SLC25A37 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of SLC25A37 intron CTD PMID:30157460 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC25A37 mRNA and [bisphenol A co-treated with Testosterone] results in increased expression of SLC25A37 mRNA CTD PMID:26496021 bisphenol A decreases expression ISO Slc25a37 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC25A37 mRNA CTD PMID:32156529 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC25A37 mRNA CTD PMID:32145629 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC25A37 mRNA CTD PMID:25181051 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of SLC25A37 mRNA CTD PMID:20864626 carbon nanotube decreases expression ISO Slc25a37 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 cobalt dichloride increases expression ISO SLC25A37 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of SLC25A37 mRNA CTD PMID:19376846 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of SLC25A37 mRNA CTD PMID:24386269 cocaine increases expression ISO SLC25A37 (Homo sapiens) 6480464 Cocaine results in increased expression of SLC25A37 mRNA CTD PMID:15009677 and PMID:16710320 copper atom multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC25A37 mRNA CTD PMID:24690739 copper(0) multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC25A37 mRNA CTD PMID:24690739 copper(II) sulfate increases expression ISO SLC25A37 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of SLC25A37 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO SLC25A37 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of SLC25A37 protein CTD PMID:35688186 coumestrol decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Coumestrol results in decreased expression of SLC25A37 mRNA CTD PMID:19167446 crocidolite asbestos affects expression ISO SLC25A37 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of SLC25A37 mRNA CTD PMID:24160326 crocidolite asbestos decreases expression ISO Slc25a37 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of SLC25A37 mRNA CTD PMID:29279043 crocidolite asbestos decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of SLC25A37 mRNA CTD PMID:29523930 cyclosporin A decreases expression ISO Slc25a37 (Mus musculus) 6480464 Cyclosporine results in decreased expression of SLC25A37 mRNA CTD PMID:19770486 cyclosporin A increases expression ISO SLC25A37 (Homo sapiens) 6480464 Cyclosporine results in increased expression of SLC25A37 mRNA CTD PMID:25562108 cyproconazole increases expression ISO Slc25a37 (Mus musculus) 6480464 cyproconazole results in increased expression of SLC25A37 mRNA CTD PMID:22334560 diarsenic trioxide multiple interactions ISO Slc25a37 (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of SLC25A37 mRNA] CTD PMID:29095437 diarsenic trioxide decreases expression ISO Slc25a37 (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of SLC25A37 mRNA CTD PMID:29095437 dibenz[a,h]anthracene decreases expression ISO Slc25a37 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO Slc25a37 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of SLC25A37 mRNA CTD PMID:21266533 disulfiram multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC25A37 mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A37 mRNA CTD PMID:27188386 elemental selenium increases expression ISO SLC25A37 (Homo sapiens) 6480464 Selenium results in increased expression of SLC25A37 mRNA CTD PMID:19244175 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC25A37 mRNA CTD PMID:29391264 entinostat multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A37 mRNA CTD PMID:27188386 entinostat decreases expression ISO SLC25A37 (Homo sapiens) 6480464 entinostat results in decreased expression of SLC25A37 mRNA CTD PMID:26272509 epoxiconazole increases expression ISO Slc25a37 (Mus musculus) 6480464 epoxiconazole results in increased expression of SLC25A37 mRNA CTD PMID:22334560 epoxiconazole affects expression ISO Slc25a37 (Mus musculus) 6480464 epoxiconazole affects the expression of SLC25A37 mRNA CTD PMID:35436446 ethanol multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Ethanol co-treated with Benzo(a)pyrene] results in increased expression of SLC25A37 mRNA CTD PMID:35412187 ethyl methanesulfonate decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLC25A37 mRNA CTD PMID:23649840 fluoranthene multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A37 mRNA CTD PMID:28329830 flutamide increases expression EXP 6480464 Flutamide results in increased expression of SLC25A37 mRNA CTD PMID:24136188 folic acid multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A37 mRNA CTD PMID:22206623 folic acid increases expression ISO Slc25a37 (Mus musculus) 6480464 Folic Acid results in increased expression of SLC25A37 mRNA CTD PMID:25629700 FR900359 affects phosphorylation ISO SLC25A37 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of SLC25A37 protein CTD PMID:37730182 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC25A37 mRNA CTD PMID:33387578 heroin increases expression ISO SLC25A37 (Homo sapiens) 6480464 Heroin results in increased expression of SLC25A37 mRNA CTD PMID:16710320 inulin multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC25A37 mRNA CTD PMID:36331819 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of SLC25A37 mRNA CTD PMID:28801915 metformin multiple interactions ISO Slc25a37 (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of SLC25A37 mRNA] CTD PMID:29095437 methapyrilene increases methylation ISO SLC25A37 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of SLC25A37 intron CTD PMID:30157460 methoxyacetic acid decreases expression EXP 6480464 methoxyacetic acid results in decreased expression of SLC25A37 mRNA CTD PMID:20864626 methyl methanesulfonate decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SLC25A37 mRNA CTD PMID:23649840 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of SLC25A37 mRNA CTD PMID:20864626 Monobutylphthalate decreases expression EXP 6480464 monobutyl phthalate results in decreased expression of SLC25A37 mRNA CTD PMID:20864626 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC25A37 mRNA CTD PMID:28801915 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of SLC25A37 mRNA CTD PMID:33484710 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC25A37 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SLC25A37 mRNA CTD PMID:25729387 ozone multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC25A37 mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SLC25A37 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SLC25A37 mRNA CTD PMID:34911549 paracetamol decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC25A37 mRNA CTD PMID:21420995 perfluorooctane-1-sulfonic acid multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC25A37 mRNA more ... CTD PMID:36331819 phenobarbital increases expression ISO Slc25a37 (Mus musculus) 6480464 Phenobarbital results in increased expression of SLC25A37 mRNA CTD PMID:19270015 phenobarbital affects expression ISO Slc25a37 (Mus musculus) 6480464 Phenobarbital affects the expression of SLC25A37 mRNA CTD PMID:23091169 phosphane increases expression EXP 6480464 phosphine results in increased expression of SLC25A37 mRNA CTD PMID:34427094 pirinixic acid multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC25A37 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO Slc25a37 (Mus musculus) 6480464 pirinixic acid results in increased expression of SLC25A37 mRNA CTD PMID:18301758 pirinixic acid decreases expression ISO Slc25a37 (Mus musculus) 6480464 pirinixic acid results in decreased expression of SLC25A37 mRNA CTD PMID:18445702 potassium chromate decreases expression ISO SLC25A37 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of SLC25A37 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile increases expression ISO Slc25a37 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of SLC25A37 mRNA CTD PMID:28903501 propiconazole increases expression ISO Slc25a37 (Mus musculus) 6480464 propiconazole results in increased expression of SLC25A37 mRNA CTD PMID:21278054 and PMID:22334560 resveratrol increases expression ISO Slc25a37 (Mus musculus) 6480464 resveratrol results in increased expression of SLC25A37 mRNA CTD PMID:22610192 rotenone increases expression ISO SLC25A37 (Homo sapiens) 6480464 Rotenone results in increased expression of SLC25A37 mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A37 mRNA CTD PMID:27188386 selenium atom increases expression ISO SLC25A37 (Homo sapiens) 6480464 Selenium results in increased expression of SLC25A37 mRNA CTD PMID:19244175 serpentine asbestos affects expression ISO SLC25A37 (Homo sapiens) 6480464 Asbestos and Serpentine affects the expression of SLC25A37 mRNA CTD PMID:24160326 silicon dioxide decreases expression ISO Slc25a37 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of SLC25A37 mRNA CTD PMID:19073995 sodium arsenite decreases expression ISO SLC25A37 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC25A37 mRNA CTD PMID:22714537 sodium arsenite affects expression ISO SLC25A37 (Homo sapiens) 6480464 sodium arsenite affects the expression of SLC25A37 mRNA CTD PMID:29319823 sunitinib increases expression ISO SLC25A37 (Homo sapiens) 6480464 Sunitinib results in increased expression of SLC25A37 mRNA CTD PMID:31533062 tamoxifen affects expression ISO Slc25a37 (Mus musculus) 6480464 Tamoxifen affects the expression of SLC25A37 mRNA CTD PMID:17555576 tamoxifen increases expression ISO Slc25a37 (Mus musculus) 6480464 Tamoxifen results in increased expression of SLC25A37 mRNA CTD PMID:17555576 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of SLC25A37 mRNA CTD PMID:26496021 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC25A37 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO Slc25a37 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of SLC25A37 mRNA CTD PMID:31919559 titanium dioxide increases expression ISO Slc25a37 (Mus musculus) 6480464 titanium dioxide results in increased expression of SLC25A37 mRNA CTD PMID:23557971 and PMID:29264374 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of SLC25A37 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC25A37 mRNA CTD PMID:25729387 trimellitic anhydride increases expression ISO Slc25a37 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of SLC25A37 mRNA CTD PMID:19042947 tungsten decreases expression ISO Slc25a37 (Mus musculus) 6480464 Tungsten results in decreased expression of SLC25A37 mRNA CTD PMID:30912803 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of SLC25A37 mRNA CTD PMID:24136188 valproic acid increases expression ISO SLC25A37 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC25A37 mRNA CTD PMID:24935251 and PMID:29154799 vincristine decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Vincristine results in decreased expression of SLC25A37 mRNA CTD PMID:23649840 zinc atom increases expression ISO SLC25A37 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of SLC25A37 mRNA CTD PMID:18356318 zinc(0) increases expression ISO SLC25A37 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of SLC25A37 mRNA CTD PMID:18356318